KDIGO Individual Optimization of Management of CKD Patients with Diabetes and CVD Comorbidities
freecme000
Published on Feb 18, 2022
VIDEO EMBED ORIGINAL SOURCE - KDIGO
https://www.youtube.com/c/KDIGO/featured
Join KDIGO in a discussion about individual optimization of management of CKD patients with diabetes and CVD comorbidities. Prof. Christoph Wanner and a multi-disciplinary panel of international experts explore new cardioâ€kidney protection therapies, such as SGLT2is and the glucagon-like receptor-1 agonists, and highlight why the relationship among cardiology, nephrology, and metabolic medicine is more important than ever.
This session was presented at the ISN World Congress of Nephrology 2021 - © International Society of Nephrology 2021. Supported by Boehringer Ingelheim Lilly.
Category
- Your Subscription
freecme000 -
Share Video
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
29:08KDIGO Clinical Practice Guideline on Diabetes Management in CKD
153 views 1351 days ago -
Watch Later
35:15Management of Hyperkalemia in Patients With Hemodialysis-Dependent CKD
170 views 1556 days ago -
Watch Later
25:08HIF Stabilizer Trials in CKD/HD Patients – What Do the Data Really Show?
155 views 1351 days ago -
Watch Later
56:07KDIGO Optimal Anemia Management in CKD: A New Paradigm in Treatment?
185 views 1351 days ago